FS Arzneimittelindustrie e.V.

Dr. Holger Diener - Geschäftsführer
Daniela von Arnim - Assistentin

Grolmanstr. 44-45
10623 Berlin

Tel.: 030 88728-1700
Fax: 030 88728-1705

Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.

Survey: Most Physicians Report Being Unaffected By Open Payments Database

The Wall Street Journal (2/20) “Pharmalot” blog reported on a new survey of physicians regarding the Open Payments database, a government-funded means of tracking payments and items of value that drug and device makers give physicians for consulting and other services. While 72% said they were aware of the database’s existence, only 53% said they were familiar with the law framework that created the database or the impact it could have on their activities. Just 46% visited the website, of which 15% admitted they were interested in what had been reported about their peers. Additionally, 76% said their participation in industry activities has remained unchanged since payments began being reported in 2013


Information on the „Freiwillige Selbstkontrolle für die Arzneimittelindustrie e. V.“ (FSA) is available at


Current News

New Press Release: Research-based pharmaceutical companies implement Transparency Code


The International Olympic Committee published its indemnity policy for the first time to increase transparency within the organization


Allergo Journal "wholeheartedly" supports the transparency initiative of the FSA


Survey: Most Physicians Report Being Unaffected By Open Payments Database.


Disclosure of payments to health professionals: Going Live


Press Contact

wbpr_ Kommunikation
Natalie Schneider
Phone: +49 89/99 59 06-25
Email: natalie.schneider@wbpr.de